The US Food and Drug Administration has taken “important steps” to implement the Modernization of Cosmetics Regulation Act, but it has not addressed the organizational changes necessary to implement the law, among other shortcomings, says the US Government Accountability Office.
MoCRA Implementation Would Benefit From ‘Better Planning’ – Government Accountability Office
US FDA has not developed an implementation plan for the Modernization of Cosmetics Regulation Act, nor a strategic workforce plan to support MoCRA rollout, the US Government Accountability Office says in a 6 December report to Congressional requesters.
More from Ingredients & Safety
• By
Reclassifying ethanol as a carcinogenic, mutagenic, or reprotoxic substance - something the European Chemicals Agency seems likely to do in the near future - would be “tantamount to a de facto ban” with “fatal consequences” for medical care in Germany, says Pharma Deutschland in a joint paper with 13 other German healthcare industry associations.
• By
Two AESGP papers reviewing the evidence for AMR risk associated with a range of OTC antifungals and antivirals conclude there is litte to no risk associated with the responsible self-care use of such medicines.
• By
“Protecting the environment is a shared responsibility. It is unfair to expect only two sectors to fund wastewater treatment modernization and operation,” argues AESGP director general Jurate Švarcaite.
• By
Supplements already under close scrutiny in the EU have been linked to severe adverse effects on the musculoskeletal system and liver, even at low doses.
More from HBW Insight
• By
Changes established in West Virginia and proposed in numerous other states gained momentum after Trump was elected to his second term as president and nominated Kennedy to head HHS.
• By
Personal care companies selling in California that suspect they are subject to its listing of a common stabilizer and packaging material should collect Certificates of Analysis for all raw materials, pursue third-party formula testing and retain counsel.
• By
Italy's Alfasigma has expanded its operation in Germany with the creation of a new Consumer Healthcare unit. Led by Rüdiger Hoppe, the business is rolling out OTC medical devices and dietary supplements in the gastrointestinal category.